FDA Approves Once-Daily HIV Pill Complera

The FDA has approved Gilead's Complera, a combination of the HIV drugs Truvada and Edurant. It's the second complete HIV treatment in a single, once-daily pill. The first, Atripla, was approved in 2006.

Click here to read the full story.

Post a Comment

Enter the words shown above Enter the numbers you hear
Refresh Image Audio Help
No comments yet!

The Health News section does not provide medical advice, diagnosis or treatment. See additional information.

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.